JP2021519589A5 - - Google Patents

Info

Publication number
JP2021519589A5
JP2021519589A5 JP2020552838A JP2020552838A JP2021519589A5 JP 2021519589 A5 JP2021519589 A5 JP 2021519589A5 JP 2020552838 A JP2020552838 A JP 2020552838A JP 2020552838 A JP2020552838 A JP 2020552838A JP 2021519589 A5 JP2021519589 A5 JP 2021519589A5
Authority
JP
Japan
Prior art keywords
seq
nos
cdr2
sequences shown
cdr3 sequences
Prior art date
Application number
JP2020552838A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519589A (ja
JPWO2019191563A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/024794 external-priority patent/WO2019191563A1/en
Publication of JP2021519589A publication Critical patent/JP2021519589A/ja
Publication of JPWO2019191563A5 publication Critical patent/JPWO2019191563A5/ja
Publication of JP2021519589A5 publication Critical patent/JP2021519589A5/ja
Pending legal-status Critical Current

Links

JP2020552838A 2018-03-29 2019-03-29 インターロイキン１７ａ（ｉｌ−１７ａ）に結合する抗体を用いた自己免疫障害及び炎症障害の治療 Pending JP2021519589A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862649854P 2018-03-29 2018-03-29
US62/649,854 2018-03-29
PCT/US2019/024794 WO2019191563A1 (en) 2018-03-29 2019-03-29 Treatment of autoimmune and inflammatory disorders using antibodies that bind interleukin-17a (il-17a)

Publications (3)

Publication Number Publication Date
JP2021519589A JP2021519589A (ja) 2021-08-12
JPWO2019191563A5 JPWO2019191563A5 (https=) 2022-03-29
JP2021519589A5 true JP2021519589A5 (https=) 2022-03-29

Family

ID=68058546

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020552838A Pending JP2021519589A (ja) 2018-03-29 2019-03-29 インターロイキン１７ａ（ｉｌ−１７ａ）に結合する抗体を用いた自己免疫障害及び炎症障害の治療

Country Status (5)

Country Link
US (1) US20210079087A1 (https=)
EP (1) EP3773717A4 (https=)
JP (1) JP2021519589A (https=)
CN (1) CN112203685A (https=)
WO (1) WO2019191563A1 (https=)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100455599C (zh) * 2000-03-03 2009-01-28 协和发酵工业株式会社 基因重组抗体及其抗体片段
US20040005615A1 (en) * 2002-05-24 2004-01-08 Jing Li Amplification and overexpression of oncogenes
DE10256900A1 (de) * 2002-11-29 2004-06-24 Nemod Immuntherapie Ag Tumorspezifische Erkennungsmoleküle
GB0417487D0 (en) * 2004-08-05 2004-09-08 Novartis Ag Organic compound
JP2009540018A (ja) * 2006-06-13 2009-11-19 ザイモジェネティクス， インコーポレイテッド Ｉｌ−１７およびｉｌ−２３アンタゴニストならびにその使用方法
TW200815469A (en) * 2006-06-23 2008-04-01 Astrazeneca Ab Compounds
CA2660463C (en) * 2006-08-11 2013-07-16 Schering Corporation Antibodies to il-17a
WO2011053763A2 (en) * 2009-10-30 2011-05-05 Centocor Ortho Biotech Inc. Il-17a antagonists
LT2953969T (lt) * 2013-02-08 2019-12-10 Novartis Ag Anti-il-17a antikūnai ir jų panaudojimas autoimuninių ir uždegiminių ligų gydymui
WO2014140368A1 (en) * 2013-03-15 2014-09-18 Amgen Research (Munich) Gmbh Antibody constructs for influenza m2 and cd3

Similar Documents

Publication Publication Date Title
JP2020508655A5 (https=)
JP2025016349A5 (https=)
JP2018522888A5 (https=)
RU2019121086A (ru) Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1)
JP2017504578A5 (https=)
JP2018506964A5 (https=)
JP2020514277A5 (https=)
JP2019532619A5 (https=)
IL259747B (en) Antibodies against fcrl5 and methods of their use
RU2010149746A (ru) Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения
JP2012525829A5 (https=)
JP2010538608A5 (https=)
FI3322727T3 (fi) Humanisoituja tai kimeerisiä CD3-vasta-aineita
JP2018526981A5 (https=)
JP2013545738A5 (https=)
RU2018102803A (ru) Мультивалентные и мультиспецифические гибридные белки, связывающиеся с dr5
US20230114801A1 (en) MINIATURE GUIDANCE AND NAVIGATION CONTROL (miniGNC) ANTIBODY-LIKE PROTEINS AND METHODS OF MAKING AND USING THEREOF
JP2020513759A5 (https=)
JP2016518333A5 (https=)
JP2020502233A5 (https=)
JP2019505477A5 (https=)
IL316226A (en) Anti-ror1 antibody and ror1-targeting engineered cells
JP2021518132A5 (https=)
JP2016529213A5 (https=)
JP2021518748A5 (https=)